Skip to content

Clinical trials

Expanded access Liver Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Phase: Expanded access Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Approved for marketing4
No longer available3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Catherine Cibulskis, MD1
Emory University1
Gilead Sciences1
H. Lee Moffitt Cancer Center and Research Institute1
Mirum Pharmaceuticals, Inc.1
Northwell Health1
The University of Texas Health Science Center at San Antonio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases7
Cholestasis4
Digestive System Diseases2
Hyperphagia2
Alagille Syndrome1
Bile Duct Diseases1
Biliary Tract Diseases1
Carcinoma, Hepatocellular1
Enterovirus Infections1
Flaviviridae Infections1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.